参考文献 References
[1] Liu DB, Wang ZY. Identification and Validation Novel Risk Genes for Autism Spectrum Disorder – A Meta-Analysis.Journal of Psychiatry and Brain Science,2017;1
(1)
: 117-127.
[2] Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M, Colantuoni C, Weinberger DR, Kleinman JE, Lipska BK. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet,2012;90
(2)
: 260-272.
[3] Horsthemke B, Wagstaff J. Mechanisms of imprinting of the Prader-Willi/Angelman region.Am J Med Genet A,2008;146A
(16)
: 2041-2052.
[4] Tatton-Brown K, Seal S, Ruark E, Harmer J, Ramsay E, Del Vecchio Duarte S, Zachariou A, Hanks S, O'Brien E, Aksglaede L, Baralle D, Dabir T, Gener B, Goudie D, Homfray T, Kumar A, Pilz DT, Selicorni A, Temple IK, Van Maldergem L, Yachelevich N; Childhood Overgrowth Consortium, van Montfort R, Rahman N. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability.Nat Genet,2014;46
(4)
: 385-388.
[5] Ramocki MB, Tavyev YJ, Peters SU. The MECP2 duplication syndrome. Am J Med Genet A,2010;152A
(5)
: 1079-1088.
[6] Zhu L, Wang X, Li XL, Towers A, Cao X, Wang P, Bowman R, Yang H, Goldstein J, Li YJ, Jiang YH. Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders.Hum Mol Genet,2014;23
(6)
: 1563-1578.
[7] Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation.Epigenetics,2006;1
(4)
: e1-11.
[8] Zhubi A, Chen Y, Dong E, Cook EH, Guidotti A, Grayson DR. Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (自闭症谱系障碍) cerebellum.Transl Psychiat,2014;4
: e349.
[9] Nguyen A, Rauch TA, Pfeifer GP, Hu VW. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain.FASEB J,2010;24
(8)
: 3036-3051.
[10] Wong CC, Meaburn EL, Ronald A, Price TS, Jeffries AR, Schalkwyk LC, Plomin R, Mill J. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits.Mol Psychiat,2014;19
(4)
: 495-503.
[11] Ladd-Acosta C, Hansen KD, Briem E, Fallin MD, Kaufmann WE, Feinberg AP. Common DNA methylation alterations in multiple brain regions in autism.Mol Psychiat,2014;19
(8)
: 862-871.
[12] Nardone S, Sams DS, Reuveni E, Getselter D, Oron O, Karpuj M, Elliott E. DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways.Transl Psychiat,2014;4
: e433.
[13] Berko ER, Suzuki M, Beren F, Lemetre C, Alaimo CM, Calder RB, Ballaban-Gil K, Gounder B, Kampf K, Kirschen J, Maqbool SB, Momin Z, Reynolds DM, Russo N, Shulman L, Stasiek E, Tozour J, Valicenti-McDermott M, Wang S, Abrahams BS, Hargitai J, Inbar D, Zhang Z, Buxbaum JD, Molholm S, Foxe JJ, Marion RW, Auton A, Greally JM. osaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder.PLoS Genet,2014;10
(5)
: e1004402.
[14] Wang Y, Fang Y, Zhang F, Xu M, Zhang J, Yan J, Ju W, Brown WT, Zhong N. Hypermethylation of the enolase gene (ENO2) in autism.Eur J Pediatr,2014;173
(9)
: 1233-1244.
[15] Mikeska T, Craig JM. DNA methylation biomarkers: cancer and beyond.Genes (Basel),2014;5
(3)
: 821-864.